What is the maximum recommended daily dose of glycopyrrolate for adults and adolescents (including oral and parenteral routes)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Maximum Dose of Glycopyrrolate

For parenteral (IV/IM) glycopyrrolate in adults, the maximum daily dose is 0.8 mg (0.2 mg given 4 times daily), and for oral glycopyrrolate in pediatric patients (ages 3-16), the maximum is 0.1 mg/kg three times daily, not to exceed 3 mg per dose. 1, 2

Parenteral (IV/IM) Dosing - Adults

The FDA-approved maximum dosing for parenteral glycopyrrolate varies by indication 1:

Peptic Ulcer (highest daily dose indication):

  • Standard dose: 0.1 mg IV/IM every 4 hours, 3-4 times daily
  • When more profound effect needed: 0.2 mg per dose
  • Maximum frequency: 4 times daily
  • This translates to a maximum daily dose of 0.8 mg (0.2 mg × 4 doses)

Other parenteral indications have lower single doses:

  • Preanesthetic medication: 0.004 mg/kg IM (single dose)
  • Intraoperative use: 0.1 mg IV, repeated every 2-3 minutes as needed
  • Reversal of neuromuscular blockade: 0.2 mg per 1 mg neostigmine (single administration)

Oral Dosing - Pediatric Patients (Ages 3-16)

For chronic severe drooling, the FDA-approved oral solution dosing is 2:

  • Starting dose: 0.02 mg/kg three times daily
  • Titration: Increase by 0.02 mg/kg every 5-7 days based on response
  • Maximum dose: 0.1 mg/kg three times daily
  • Absolute maximum per dose: 1.5-3 mg depending on weight (see weight-based table)
  • Highest single dose: 3 mg (for patients ≥28 kg)
  • Maximum daily dose: 9 mg (3 mg × 3 doses for patients ≥28 kg)

Weight-Based Maximum Dosing Table

For patients at maximum dose level (0.1 mg/kg TID) 2:

  • 13-17 kg: 1.5 mg per dose (4.5 mg/day)
  • 18-22 kg: 2.0 mg per dose (6 mg/day)
  • 23-27 kg: 2.5 mg per dose (7.5 mg/day)
  • ≥28 kg: 3.0 mg per dose (9 mg/day)

Pediatric Parenteral Dosing

For pediatric patients requiring parenteral administration 1:

Preanesthetic medication:

  • Standard: 0.004 mg/kg IM
  • Infants (1 month-2 years): up to 0.009 mg/kg

Intraoperative:

  • 0.004 mg/kg IV, not to exceed 0.1 mg single dose
  • May repeat every 2-3 minutes as needed

Reversal of neuromuscular blockade:

  • 0.2 mg per 1 mg neostigmine (same as adults)

Important Clinical Considerations

Timing with meals (oral formulation): Administer at least 1 hour before or 2 hours after meals, as high-fat food significantly reduces bioavailability 2.

Dose-limiting adverse effects: Constipation is the most common reason for discontinuation, particularly within 4-5 days of initiation or dose increase 2. Monitor bowel function closely when approaching maximum doses.

Contraindications at any dose: Do not use in patients with glaucoma, paralytic ileus, unstable cardiovascular status, severe ulcerative colitis, toxic megacolon, or myasthenia gravis 2.

Renal impairment: Use with caution in renal impairment as glycopyrrolate is renally excreted; dose reduction may be necessary 2.

Pediatric use limitation: Glycopyrrolate injection is not recommended for peptic ulcer treatment in pediatric patients 1.

References

Related Questions

What is the recommended dosing and management of glycopyrrolate for an elderly patient with excessive drooling?
What is the recommended dose of Glycopyrolate for a typical adult patient with no significant renal or hepatic impairment?
What is the recommended oral dose of glycopyrrolate (anticholinergic medication) for an adult patient with no significant renal (kidney) or hepatic (liver) impairment?
What dose of glycopyrrolate syrup (1 mg per 5 ml) should be administered to children based on weight and to adults?
What is the appropriate dosage of glycopyrrolate for treating sialorrhea in a 70-year-old patient with Parkinson’s disease, and what precautions should be considered?
Which hydrocortisone preparation should be prescribed for vaginal use in this patient?
What advice should be given to the mother of an 8‑month‑old infant who accidentally ingested a small amount of raw honey?
Does celecoxib (Celebrex) help relieve toothache pain?
How many weeks will a 10 mL vial of testosterone (200 mg/mL) last when administered at 0.5 mL per week?
What are the differences between ventricular septal defect with pulmonary stenosis and Tetralogy of Fallot?
What does a fading control line in an IgM dengue rapid test kit indicate, and how should it be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.